SCHEMBL2741574

SCHEMBL2741574

CCCCc1ccc(-c2ccc(-c3ccc(C)cc3)cc2F)s1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ESR1 P03372 2/20 0.37
▸ ESR2 Q92731 2/20 0.37
▸ RARB P10826 4/20 0.35
▸ RARA P10276 2/20 0.35
▸ RARG P13631 1/20 0.35
▸ PDE3B Q13370 1/20 0.33
▸ PDE3A Q14432 1/20 0.33
▸ CYP1A2 P05177 1/20 0.32
▸ CYP2E1 P05181 1/20 0.32
▸ CYP3A4 P08684 1/20 0.32
▸ CYP2C8 P10632 1/20 0.32
▸ CYP2D6 P10635 1/20 0.32
▸ CYP2A6 P11509 1/20 0.32
▸ CYP2C9 P11712 1/20 0.32
▸ CYP2B6 P20813 1/20 0.32
▸ CYP2C19 P33261 1/20 0.32
▸ MAPT P10636 2/20 0.32
▸ POLB P06746 2/20 0.31
▸ ALDH1A1 P00352 2/20 0.31
▸ MEN1 O00255 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2847898 0.88 ESR1 (0.45) ESR1ESR2RARBRARARARG
SCHEMBL1533776 0.88 RARB (0.42) ESR1ESR2RARBRARARARG
SCHEMBL1533757 0.88 RARB (0.40) ESR1ESR2RARBRARARARG
SCHEMBL1533783 0.85 RARB (0.47) ESR1ESR2RARBRARARARG
SCHEMBL1533759 0.85 RARB (0.44) ESR1ESR2RARBRARARARG
SCHEMBL225334 0.83 RARB (0.43) RARBRARARARGCYP1A2CYP3A4
SCHEMBL26481767 0.82 RARB (0.38) RARBRARARARGMAPTKDM4E
SCHEMBL1533774 0.81 RARB (0.39) ESR1ESR2RARBRARARARG
SCHEMBL24300962 0.81 ESR1 (0.35) ESR1ESR2PDE3BPDE3A
SCHEMBL24300950 0.81 ESR1 (0.31) ESR1ESR2PDE3BPDE3A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8486297-B2 Thiophene derivatives, and LC media comprising same MERCK PATENT GMBH (DE) 2013-07-16 — — US disclosed
US-8394293-B2 Thiophene derivatives, and LC media containing same MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2013-03-12 — — US disclosed
US-20120001123-A1 THIOPHENE DERIVATIVES, AND LC MEDIA COMPRISING SAME MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2012-01-05 — — US disclosed
US-20110049427-A1 Thiophene derivatives, and LC media containing same MERCK PATENT GESELLSCHAFT (DE) 2011-03-03 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120001123-A1 THIOPHENE DERIVATIVES, AND LC MEDIA COMPRISING SAME TEC, TPMT, TST ESR1 2491/4885ESR2 3634/4885RARB 3907/4885
US-20110049427-A1 Thiophene derivatives, and LC media containing same TPMT, TEC, LCT ESR1 2560/4885ESR2 3647/4885RARB 3984/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback